Fennec Pharmaceuticals Inc (FENC)
SG&A Expense Growth
4.72%
Quarterly · Period ending:
FENC SG&A Expense Growth
Latest reported4.72%period ending
Latest reported4.72%period ending
FENC Quarterly SG&A Growth (QoQ) (0.00% → 4.72%)
Latest values, visible window
High-resolution chart · PNG
FENC sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0% | |
| -100% | |
| 0% | |
| 0% |